Scientists identify a new method to treat triple-negative breast cancer
Drugs like PARP inhibitors, immunotherapy, and antibody-drug conjugates are revolutionising the treatment of breast cancer patients with various subtypes Breast cancer clinical trials have been focusing on therapy alternatives with high response rates and fewer side effects, which could change the landscape

